Related Experiment Videos
Drug Resistance Patterns, Temporal Trends, and Risk Factors Among Elderly Tuberculosis Patients in Anhui, China: A
Kexue Yu1, Yuling Yang1, Xuan Teng1
1Department of Clinical Laboratory, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, People's Republic of China.
Purpose:
To investigate the drug resistance profiles, epidemiological dynamics, and risk factors of Mycobacterium tuberculosis (M. tuberculosis) clinical isolates among geriatric patients (aged ≥ 60 years) in Anhui Province. The findings are intended to inform the formulation of targeted intervention strategies for drug-resistant tuberculosis (DR-TB) control in this demographic.
Methods:
A retrospective analysis was performed on the clinical records and drug susceptibility testing results of M. tuberculosis strains isolated from geriatric patients at Anhui Chest Hospital (January 2020 to December 2024). Resistance characteristics and temporal trends regarding the overall prevalence, four distinct phenotypes, and 12 anti-TB drugs were systematically analyzed. Independent risk factors for drug resistance were determined using univariable and multivariable logistic regression models.
Results:
Among 2752 M. tuberculosis isolates, the overall drug resistance rate was 21.91%. Rifampicin-resistant TB (RR-TB) and multidrug-resistant TB (MDR-TB) accounted for 10.17% and 6.14% of the isolates, respectively. The drug resistance burden was disproportionately concentrated among individuals with clinical comorbidities and those within the 60-69 age cohort. Ninety-three resistance combinations were identified, with isoniazid, rifampicin, and streptomycin showing the highest resistance rates among the 12 tested drugs. Longitudinally (2020-2024), rates of overall isoniazid resistance and the specific Hr-TB phenotype (isoniazid-resistant, rifampicin-susceptible) decreased. Conversely, resistance to rifabutin, moxifloxacin, levofloxacin, and para-aminosalicylic acid increased (all P < 0.05). Cross-resistance was observed among rifamycins, fluoroquinolones, and second-line injectable drugs. Retreatment and concurrent chronic pulmonary disease were confirmed as independent risk factors for resistance, while advancing age correlated paradoxically with a reduced risk.
Conclusion:
Drug resistance among geriatric TB patients in Anhui remains critical, driven independently by retreatment and chronic pulmonary disease. Despite declining INH resistance, the rising resistance to fluoroquinolones and secondary agents demands vigilance. Policymakers should prioritize targeted screening for high-risk cohorts and integrated comorbidity management to optimize therapeutic outcomes and curb regional transmission.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drug Dosing: Geriatric Patients
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Drug Toxicity: Risk factors